OsteoMAX-XF™ Differentiation Medium by MilliporeSigma

Manufacturer MilliporeSigma
EMD Millipore’s OsteoMAX-XF™ Differentiation Medium is specially formulated to readily differentiate human mesenchymal stem cells into the osteogenic lineage as assessed by alizarin red and alkaline phosphatase staining. This proprietary formulation was developed using Plasticell’s CombiCultTM, a patented, bead-based, combinatorial technology specially developed for discovery of novel stem cell differentiation protocols. The unique characteristics of OsteoMAX-XF™ Differentiation Medium include: ... Read more


OsteoMAX-XF™ Differentiation Medium by MilliporeSigma product image
OsteoMAX-XF™ Differentiation Medium

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.



0 Scientists have reviewed this product


Write the First Review

No Reviews

EMD Millipore’s OsteoMAX-XF™ Differentiation Medium is specially formulated to readily differentiate human mesenchymal stem cells into the osteogenic lineage as assessed by alizarin red and alkaline phosphatase staining. This proprietary formulation was developed using Plasticell’s CombiCultTM, a patented, bead-based, combinatorial technology specially developed for discovery of novel stem cell differentiation protocols. The unique characteristics of OsteoMAX-XF™ Differentiation Medium include: 1) Serum-free, xeno-free, defined medium formulation and 2) Rapid, robust, and highly efficient mineralization and bone nodule formation in standard tissue culture system by as early as 7 days of differentiation.

Using EMD Millipore's OsteoMAX-XF™ Differentiation Media, we typically obtain >80% mature osteocytes from bone marrow derived mesenchymal stem cells. Efficiency of osteogenic differentiation may vary, depending upon the source and quality of the mesenchymal stem cells and if variations to the protocol are introduced.